PTSDAdolescentsSubstance Use Disorders (SUD)MDMA

Self-reported PTSD is associated with increased use of MDMA in adolescents with substance use disorders

This survey study (n=121) explored the co-occurrence of PTSD in patients with a substance use disorder (SUD). It was found that SUD patients with PTSD were more likely to use MDMA than those without PTSD and MDMA use was associated with avoidance symptoms. The authors conclude that MDMA use might reflect an attempt to self-medicate to deal with avoidance symptoms however, it may also be the case that MDMA use led to more severe avoidance symptoms.

Authors

  • Basedow, L. A.
  • Kuitunen-Paul, S.
  • Wiedmann, M. F.

Published

European Journal of Psychotraumatology
individual Study

Abstract

Background

Adolescent patients with a substance use disorder (SUD) often fulfil the criteria for a co-occurring post-traumatic stress disorder (PTSD). However, it is not clear if these dual-diagnosed adolescents present with unique levels of substance use and how their substance use relates to PTSD symptom clusters.

Objective

To investigate substance use in adolescents with co-occurring PTSD and SUD. Additionally, we explored how the use of specific substances is related to specific PTSD symptom clusters.

Method

We recruited n = 121 German adolescent SUD patients, in three groups: no history of traumatic events (TEs) (n = 35), TEs but not PTSD (n = 48), probable PTSD (n = 38). All groups were administered a trauma questionnaire and were asked to report their past-month substance use.

Results

Adolescents with probable PTSD and SUD report a higher frequency of MDMA use than adolescents with no PTSD and no TE (PTSD vs. no TE: U = 510.5, p = .016; PTSD vs. TE: U = 710.0, p = .010). The use of MDMA was more frequent in adolescents with avoidance symptoms (X2 (1) = 6.0, p = .014). Participants report using substances at a younger age (PTSD vs. no TE: U = 372.0, p = .001; PTSD vs. TE: U = 653.5, p = .022) and PTSD symptom onset was on average 2.2 years earlier than first MDMA use (t (26) = −2.89, p = .008).

Conclusions

Adolescent SUD patients with probable PTSD are more likely to use MDMA than SUD patients without PTSD. The use of MDMA was associated with reported avoidance symptoms. The first age of MDMA use is initiated after PTSD onset. It is unclear whether the association of MDMA use with avoidance symptoms is due to efforts to reduce these symptoms or a result of regular MDMA use.

Available with Blossom Pro

Research Summary of 'Self-reported PTSD is associated with increased use of MDMA in adolescents with substance use disorders'

Introduction

Lukas and colleagues situate their study in the context of frequent co-occurrence between post-traumatic stress disorder (PTSD) and substance use disorders (SUDs) in adolescents, noting that 20–54% of adolescent SUD patients may meet PTSD criteria while about 30% of adolescent PTSD patients present with SUD. They outline three explanatory frameworks for this co-occurrence: shared genetic or environmental risk, increased exposure to traumatic events (TEs) via high‑risk behaviour, and the self‑medication hypothesis in which PTSD symptoms precede and motivate substance use. The authors note that prior work has established greater SUD severity in adolescents with co-occurring PTSD, but that little is known about the use of specific substances in relation to specific PTSD symptom clusters (intrusion, avoidance, hyperarousal) in this age group. This cross‑sectional exploratory study therefore set out to compare past‑month substance use frequencies across three subgroups of treatment‑seeking adolescent SUD patients — those without trauma exposure (NoTE), those with trauma exposure but not PTSD (TE), and those with probable PTSD — and to examine whether use of particular substances relates to the three PTSD symptom clusters. A secondary aim was to compare ages of first substance use across groups and to test whether onset of PTSD symptoms preceded first use of particular substances, as predicted by the self‑medication hypothesis.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

References (6)

Papers cited by this study that are also in Blossom

Greater empathy in MDMA users

Carlyle, M., Stevens, T., Fawaz, L. et al. · Journal of Psychopharmacology (2019)

Transient memory impairment after acute dose of 75mg 3.4-Methylene-dioxymethamphetamine

Kuypers, K. P. C., Ramaekers, J. G. · Journal of Psychopharmacology (2005)

83 cited
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study

Mitchell, J., Bogenschutz, M. P., Lilienstein, A. et al. · Nature Medicine (2021)

Human pharmacology of mephedrone in comparison with MDMA

Papaseit, E., Pérez-Mañá, C., Mateus, J. A. et al. · Neuropsychopharmacology (2016)

Effects of ecstasy on cooperative behaviour and perception of trustworthiness: A naturalistic study

Stewart, L., Ferguson, B., Morgan, C. J. A. et al. · Journal of Psychopharmacology (2014)

Safety pharmacology of acute MDMA administration in healthy subjects

Vizeli, P., Liechti, M. E. · Journal of Psychopharmacology (2017)

Cited By (1)

Papers in Blossom that reference this study

MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations

Kangaslampi, S., Zijlmans, J. · European Child and Adolescent Psychiatry (2023)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.

Self-reported PTSD is associated with increased... — Research Summary & Context | Blossom